Skip to main content
Log in

Identification and characterisation of adducts between serum albumin and 4,4’-methylenediphenyl diisocyanate (MDI) in human plasma

  • Toxicokinetics and Metabolism
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Diisocyanates are potent inducers of airways disease. Methylenediphenyl diisocyanate (MDI) is a widely used diisocyanate in the chemical industry. The aim of this study was to identify major and also immunologically relevant protein conjugates of MDI in plasma. Plasma was obtained from an MDI-exposed worker. The plasma was dialysed and then fractionated using ion exchange chromatography (IEC) and gel filtration. These fractions and also aliquots of unfractioned plasma were hydrolysed, derivatised and analysed for isocyanate adduct content using gas chromatography–mass spectrometry. In addition, immunologically relevant proteins were identified through specific IgG immunoblotting using pooled sera from two exposed workers. It was shown by dialysis that 96% of the hydrolysed MDI derivatives were protein bound and that 95% of the MDI adducts co-eluted with serum albumin in plasma using IEC. All MDI–protein adducts co-eluted with serum albumin using gel filtration. IgG immunoblotting showed a major 66 kDa protein and also some intermolecular reactions in serum albumin. This study shows serum albumin to be the major protein in plasma that forms adducts in vivo with MDI. Thus, a quick and simple quantitative method for biological monitoring may be developed for MDI exposure. The results also showed that MDI-specific IgG antibodies preferentially bind to the serum albumin in in-vitro-synthesised MDI–plasma protein conjugates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3A,B

Similar content being viewed by others

References

  • Baur X, Marek W, Ammon J, Czuppon AB, Marczynski B, Raulf-Heimsoth M, Roemmelt H, Fruhmann G (1994) Respiratory and other hazards of isocyanates. Int Arch Occup Environ Health. 66:141–152

    Google Scholar 

  • Dalene M, Skarping G, Lind P (1997) Workers exposed to thermal degradation products of TDI- and MDI-based polyurethane: biomonitoring of 2,4-TDA, 2,6-TDA, and 4,4′-MDA in hydrolyzed urine and plasma. Am Ind Hyg Assoc J 58:587–591

    Article  PubMed  Google Scholar 

  • Ehrenberg L, Hiesche KD, Osterman-Golkar S, Wenneberg I (1974) Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res 24:83–103

    Article  CAS  PubMed  Google Scholar 

  • Jin RZ, Karol MH (1988) Intra- and intermolecular reactions of 4,4′-diisocyanatodiphenylmethane with human serum albumin. Chem Res Toxicol 1:281–287

    PubMed  Google Scholar 

  • Johannesson G, Rosqvist S, Lindh CH, Welinder H, Jönsson BAG (2001) Serum albumins are the major site for in vivo formation of hapten-carrier protein adducts in plasma from humans and guinea-pigs exposed to type-1 allergy inducing hexahydrophthalic anhydride. Clin Exp Allergy 31:1021–1030

    Article  PubMed  Google Scholar 

  • Johansson B (1972) Agarose gel electrophoresis. Scand J Clin Lab Invest 29 [Suppl 124]:7–20

  • Lind P, Dalene M, Lindstrom V, Grubb A, Skarping G (1997) Albumin adducts in plasma from workers exposed to toluene diisocyanate. Analyst 122:151–154

    Article  PubMed  Google Scholar 

  • Schütze D, Sepai O, Lewalter J, Miksche L, Henschler D, Sabbioni G (1995) Biomonitoring of workers exposed to 4,4′-methylenedianiline or 4,4′-methylenediphenyl diisocyanate. Carcinogenesis 16:573–582

    PubMed  Google Scholar 

  • Sennbro CJ, Lindh CH, Tinnerberg H, Gustavsson C, Littorin M, Welinder H, Jonsson BA (2003) Development, validation and characterization of an analytical method for the quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4- and 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate and 4,4′-methylenediphenyl diisocyanate. Biomarkers 8:204–217

    Article  PubMed  Google Scholar 

  • Sepai O, Henschler D, Sabbioni G (1995) Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,4′-methylenediphenyl diisocyanate. Carcinogenesis 16:2583–2587

    PubMed  Google Scholar 

  • Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850–858

    Article  CAS  PubMed  Google Scholar 

  • Spanne M, Tinnerberg H, Dalene M, Skarping G (1997) Determination of complex mixtures of airborne isocyanates and amines. Part 1. Liquid chromatography with ultraviolet detection of monomeric and polymeric isocyanates as their dibutylamine derivatives. Analyst 121:1095–1099

    Google Scholar 

  • Wisnewski AV, Srivastava R, Herick C, Xu L, Lemus R, Cain H, Magoski NM, Karol MH, Bottomly K, Redlich CA (2000) Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med 162:2330–2336

    PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Swedish Council for Work Life Research, the AFA Foundation, the Swedish Research Council and the Medical Faculty at Lund University. The experiments complied with the current laws in Sweden.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Johannesson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johannesson, G., Sennbro, C.J., Willix, P. et al. Identification and characterisation of adducts between serum albumin and 4,4’-methylenediphenyl diisocyanate (MDI) in human plasma. Arch Toxicol 78, 378–383 (2004). https://doi.org/10.1007/s00204-004-0555-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-004-0555-2

Keywords

Navigation